跳至主要内容
临床试验/NCT01844037
NCT01844037终止2 期

Renal Denervation Using the OneShot Ablation System

Medtronic Endovascular1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2014年7月1日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
51
试验地点
1
主要终点
Change in office systolic blood pressure (SBP) from baseline to 6 months

研究概览

简要总结

This is a multi-center, prospective registry designed to monitor the outcomes of renal denervation with the OneShot Device in a real-world patient population.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is an acceptable candidate for renal denervation based upon the Instructions for Use.
  • Patient is ≥ 18 years old.
  • Patient provided written informed consent.

排除标准

  • Patients who are pregnant, nursing, or planning to become pregnant.
  • Patients who have only one functioning kidney.
  • Allergy to contrast or known hypersensitivity to device materials
  • Patients with renal arteries < 4 mm in diameter.
  • Patients whose life expectancy is less than the planned period of study involvement.

结局指标

主要结局

Change in office systolic blood pressure (SBP) from baseline to 6 months

时间窗: 6 months

次要结局

  • Change in office diastolic blood pressure (DBP)(6 and 12 months post procedure)
  • Change in office SBP(6 and 12 months post procedure)
  • Acute procedural safety, defined as freedom from renal artery dissection or perforation requiring intervention.(One Week)

研究者

发起方
Medtronic Endovascular
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验